TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change From Baseline to End of Treatment in Total International Prostate Symptom Score (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication With Physician - Stanford 3Q Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient-Reported Outcome Measurement Information System (PROMIS) Self-efficacy for Managing Medications and Treatments Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PROMIS Global Health Physical Health Domain Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Overall survival (OS) from initiation of 2L therapy of Radium-223
Endpoint domain: Mortality/survival
Primary endpoint: Overall survival (OS) from initiation of 2L therapy of sequential NAH
Endpoint domain: Mortality/survival
Primary endpoint: Mean % TBWL at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subjects with greater than/equal to 5% TBWL at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Procedure/device related Adverse Events thru 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Recurrence of keloid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Satisfactory service regarding hospital response to COVID-19
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cellular response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reliability under test retest conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: P100 latency of the Visual Evoked Potential
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: No structural or biochemical abnormality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time spent in sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Overall benefit of analgesia score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Type viral characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tracheal intubation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total time of intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of antibiotic associated diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute change in minimal lumen area (MLA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Circulating RAS Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Percentage Change in Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in pain disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Coronary artery atheroma volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Acceptability of the LIFE-MATTERS program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: day 100 mortality
Endpoint domain: Mortality/survival
Primary endpoint: acute GVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change From Baseline QTc Intervals (ddQTc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum tolerated dose of DI-Leu16-IL2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimal biologic dose of DI-Leu16-IL2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicities associated with the DI-Leu16-IL2 regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in NOSE Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Immunogenicity measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Detection of DCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OAB symptom score (OABSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Congenital birth defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of MEDI-573
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Penetration-Aspiration Scale (PAS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder Status
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Remission Status
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient Global Rating of Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall rate of serious adverse device effects
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Hb A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dupaul ADHD Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Vessel wall stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Area under the concentration versus time curve (AUC) in blood plasma after a single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak concentration (Cmax) in blood plasma after a single dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term morbidity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in weekly purchases of recipe components
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Participants With 20% Improvement in ACR Criteria (ACR20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: clinical laboratory abnormalities defined as dose limiting toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Enumeration of S. mutans in saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Enumeration of seven periodontal pathogens in subgingival plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pulmonary Vascular Permeability Index (PVPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lung LPA1 percentage receptor occupancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cooperation rate
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cold-induced glucose uptake in BAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of healthcare providers providing standard pneumonia case management
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Area Under the Effect Curve From Time Zero to 24 Hours Postdose of 5-hydroxytryptamine (5-HT) in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration of 5-HT in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Concentration of 5-HT in Plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of small consumers of fruits and vegetables
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Range of motion of ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Range of motion of lumbar spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tobramycin Tear Concentration Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of arrhythmia post operative
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: pain management
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in adipose tissue inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of arm/hand function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration (Cmax) of MNTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences of mortality rates between infants with prenatal diagnosis and those with postnatal diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: GI side effect burden
Endpoint domain: Adverse events/effects
Primary endpoint: CNS side effect burden
Endpoint domain: Adverse events/effects
Primary endpoint: Hemi-diaphragmatic pariesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of epidural attempts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Fatigue Related Cancer
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Neutrophil response suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Subjective fear (SUDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Crying and fussing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal exercise performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expired air carbon monoxide as measure of smoking status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Behavioral impulsivity and response inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway safety during swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total post-operative morphine requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Correction of VitD insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SENAS Executive Function Composite Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Salvage of eye and vision
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete histologic regression of all CIN 3 lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of participants with hypocalcemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Revisit to health center facility with relapse of anaphylaxis
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quantity of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Clinician Administered PTSD Scale (CAPS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported hip function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Alzheimer Disease Functional Assessment and Change Scale (ADFACS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of Index Subjects Free of Any Lice
Endpoint domain: Adverse events/effects
Primary endpoint: Level of polymorphisms of IL-12RB1 and TNF-α
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Uptake of timed appointment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: joint position sense Analysis (proprioception)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gait analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum jump height (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Euroquol 5 Dimensions (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients with clinical cure at day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year Overall survival rate
Endpoint domain: Mortality/survival
Primary endpoint: 5-year Disease-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Estimated intra-operative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Lung function by spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Allergen concentration for specific bronchoprovocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in UD iBMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with fungal DNAmia detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of individual fungal pathogens during febrile neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Frequency of fungal pathogens resistant to antifungal agents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of patients with potentially inappropriate prescriptions (PIP)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean number of PIP per patient
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Contact Lens Comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of patients with no incidence of device and/or procedure related Major Adverse Events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with Procedure Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Combined event of cardiovascular death/re-myocardial infarction/revascularization/admission due to heart failure
Endpoint domain: Mortality/survival
Primary endpoint: mean change in serum ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Biological marker of Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Connectedness scale to media
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Intention of drinking and/or smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: anti-müllerian hormone (AMH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: antral follicle count (AFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: change in KCCQ summary scores for health-related QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Acceptability and likability of the platform
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severe Transfusion Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Thirst Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea and Vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in WOMAC Physical Function Subscale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Standard Uptake Value Ratios (SUVRs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants with delayed bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of participants with coagulation syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of 2-hydroxyglutarate (2HG) bio-marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Feasibility of obtaining serial scans
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Changed Score on SF-12 Pain Items
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: clinical and mycological cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weekly change in Hamilton rating scale for depression (HRSD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maternal serum ferritin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: blood loss after placental delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mean Change From Baseline in Subject-rated Instantaneous TNSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of subclinical nail involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: BMI for change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat % for change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Melatonin Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Clinical Global Impression - Improvement ≤ 2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse events associated with surgery or stimulation
Endpoint domain: Adverse events/effects
Primary endpoint: Eating Disorder pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in lung impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in subjective dry mouth score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in electrical activity of neuron cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Short term continuous abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breast milk immune regulators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent time in target range for oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of SYDNEY-Associated Product Technical Complaints (PTCs) (Overall)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of SYDNEY-Associated Product Technical Complaints (PTCs) (by Type)
Endpoint domain: Adverse events/effects
Primary endpoint: proportion of sustained responders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiospecific enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hepatic enzymes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cortical activation patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MADRS Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: STAI YB
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trough vancomycin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient self-rated experience using the study software
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to First Perceptible Relief
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in serum lipoprotein(a)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: In-vehicle Excess Particulate Matter (PM) Exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of pneumothorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maternal weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Child weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in static and dynamic TMD pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence and severity of all adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Weekly Mean Pain Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post-operative narcotic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Frequency of Hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intraabdominal abscess resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes